拱东医疗
(605369)
| 流通市值：50.44亿 | | | 总市值：50.44亿 |
| 流通股本：1.58亿 | | | 总股本：1.58亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 836,032,757.64 | 553,724,423.6 | 271,918,455.78 | 975,084,441.93 |
| 营业收入 | 836,032,757.64 | 553,724,423.6 | 271,918,455.78 | 975,084,441.93 |
| 二、营业总成本 | 683,540,594.88 | 449,296,008.47 | 222,178,192.97 | 859,621,158.16 |
| 营业成本 | 557,189,630.4 | 369,789,789.5 | 181,807,673.77 | 656,691,776.09 |
| 税金及附加 | 7,534,668.88 | 4,364,467.51 | 2,443,100.36 | 11,013,803.44 |
| 销售费用 | 34,257,821.93 | 24,026,114.3 | 13,135,191.37 | 65,146,629.35 |
| 管理费用 | 62,169,938.79 | 41,444,863.5 | 21,860,644.13 | 83,052,961.41 |
| 研发费用 | 36,769,587.06 | 23,675,602.46 | 11,134,804.13 | 47,814,839.25 |
| 财务费用 | -14,381,052.18 | -14,004,828.8 | -8,203,220.79 | -4,098,851.38 |
| 其中:利息费用 | 1,676,334.13 | 752,021.17 | 448,868.56 | 1,447,716.19 |
| 其中:利息收入 | 15,816,694.72 | 12,528,737.85 | 8,165,188.57 | 11,171,112.57 |
| 加:投资收益 | 7,317,960.73 | 4,321,547.16 | 2,543,115.69 | 6,500,736.79 |
| 资产处置收益 | 6,024.33 | 6,024.33 | 6,024.33 | - |
| 资产减值损失(新) | -450,956.29 | -450,956.29 | -450,956.3 | -7,332,445.62 |
| 信用减值损失(新) | -3,544,850.21 | -3,106,210.55 | -975,657 | 351,173.62 |
| 其他收益 | 2,579,371.91 | 1,917,131.56 | 1,276,496.19 | 4,737,867.1 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 158,399,713.23 | 107,115,951.34 | 52,139,285.72 | 119,720,615.66 |
| 加:营业外收入 | 315,331.07 | 314,434.79 | 35.54 | 287,787.53 |
| 减:营业外支出 | 605,698.1 | 305,698.1 | 72,868.04 | 783,155.13 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 158,109,346.2 | 107,124,688.03 | 52,066,453.22 | 119,225,248.06 |
| 减:所得税费用 | 16,726,505.45 | 11,831,008.07 | 6,957,469.53 | 10,099,494.87 |
| 六、净利润 | 141,382,840.75 | 95,293,679.96 | 45,108,983.69 | 109,125,753.19 |
| 持续经营净利润 | 141,382,840.75 | 95,293,679.96 | 45,108,983.69 | 109,125,753.19 |
| 归属于母公司股东的净利润 | 141,396,726.29 | 95,293,679.96 | 45,108,983.69 | 109,125,753.19 |
| 少数股东损益 | -13,885.54 | - | - | - |
| (一)基本每股收益 | 0.9 | 0.85 | 0.4 | 0.97 |
| (二)稀释每股收益 | 0.9 | 0.85 | 0.4 | 0.97 |
| 八、其他综合收益 | -5,610,871.98 | 1,702,460.45 | 116,508.64 | 14,965,867.44 |
| 归属于母公司股东的其他综合收益 | -5,610,871.98 | 1,702,460.45 | 116,508.64 | 14,965,867.44 |
| 九、综合收益总额 | 135,771,968.77 | 96,996,140.41 | 45,225,492.33 | 124,091,620.63 |
| 归属于母公司股东的综合收益总额 | 135,785,854.31 | 96,996,140.41 | 45,225,492.33 | 124,091,620.63 |
| 归属于少数股东的综合收益总额 | -13,885.54 | - | - | 0 |
| 公告日期 | 2024-10-30 | 2024-08-27 | 2024-04-27 | 2024-04-27 |
| 审计意见(境内) | | | | 标准无保留意见 |